Cargando…

Identification of Influenza PA(N) Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening

Structural and biochemical studies elucidate that PA(N) may contribute to the host protein shutdown observed during influenza A infection. Thus, inhibition of the endonuclease activity of viral RdRP is an attractive approach for novel antiviral therapy. In order to envisage structurally diverse nove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chao, Xiang, Junjie, Xie, Qian, Zhao, Jing, Zhang, Hong, Huang, Erfang, Shaw, Pangchui, Liu, Xiaoping, Hu, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659138/ https://www.ncbi.nlm.nih.gov/pubmed/34885710 http://dx.doi.org/10.3390/molecules26237129

Ejemplares similares

Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor
por: Meng, Xin, et al.
Publicado: (2021)

Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease
por: DuBois, Rebecca M., et al.
Publicado: (2012)

N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes
por: Carcelli, Mauro, et al.
Publicado: (2016)

Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
por: Ren, Ji-Xia, et al.
Publicado: (2020)

Virtual docking screening and QSAR studies to explore AKT and mTOR inhibitors acting on PI3K in cancers
por: Kandoussi, Ilham, et al.
Publicado: (2020)

Functional properties of the novel PA-X endonuclease of human influenza virus
por: Bavagnoli, Laura, et al.
Publicado: (2014)

Evaluation of QSAR Equations for Virtual Screening
por: Spiegel, Jacob, et al.
Publicado: (2020)

An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA
por: Zhao, Jianyuan, et al.
Publicado: (2022)

A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase
por: Yuan, Shuofeng, et al.
Publicado: (2016)

Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors
por: Jones, Jeremy C., et al.
Publicado: (2018)

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
por: Mirzaei, Salimeh, et al.
Publicado: (2021)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
por: Ganji, Mahmoud, et al.
Publicado: (2023)

Corrigendum to “3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity”
por: Mirzaei, Salimeh, et al.
Publicado: (2022)

Molecular Docking and Virtual Screening of an Influenza Virus Inhibitor That Disrupts Protein–Protein Interactions
por: Ren, Yixin, et al.
Publicado: (2021)

Author Correction: An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA
por: Zhao, Jianyuan, et al.
Publicado: (2023)

Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors
por: Lu, Shuai, et al.
Publicado: (2011)

PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor
por: Luo, Dan, et al.
Publicado: (2023)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

Fragment-Based Identification of Influenza Endonuclease Inhibitors
por: Credille, Cy V., et al.
Publicado: (2016)

Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches
por: Bakal, Ravindra L., et al.
Publicado: (2022)

Virtual screening of RAGE inhibitors using molecular docking
por: Devi Alaparthi, Malini, et al.
Publicado: (2016)

Identification of Novel Influenza Polymerase PB2 Inhibitors Using a Cascade Docking Virtual Screening Approach
por: Zhao, Lei, et al.
Publicado: (2020)

Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors
por: Zhou, Nannan, et al.
Publicado: (2015)

2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors
por: Zhao, Manman, et al.
Publicado: (2017)

In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
por: Abdullahi, Mustapha, et al.
Publicado: (2022)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Virtual Screening and Molecular Design Based on Hierarchical Qsar Technology
por: Kuz’min, Victor E., et al.
Publicado: (2009)

A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors
por: Xie, Huiding, et al.
Publicado: (2015)

Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening
por: Lo, Chun-Yeung, et al.
Publicado: (2018)

3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors
por: Fang, Yajing, et al.
Publicado: (2016)

Correction to Fragment-Based Identification of Influenza Endonuclease Inhibitors
por: Credille, Cy V., et al.
Publicado: (2017)

Structure Optimization of Neuraminidase Inhibitors as Potential Anti-Influenza (H1N1Inhibitors) Agents Using QSAR and Molecular Docking Studies
por: Inamdar, Poonam, et al.
Publicado: (2014)

The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA
por: Bavagnoli, Laura, et al.
Publicado: (2015)

3D QSAR Studies, Pharmacophore Modeling and Virtual Screening on a Series of Steroidal Aromatase Inhibitors
por: Xie, Huiding, et al.
Publicado: (2014)

Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations
por: Abuelizz, Hatem A., et al.
Publicado: (2023)

Author Correction for Jones et al., “Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors”
por: Jones, Jeremy C., et al.
Publicado: (2018)

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
por: Rosell-Hidalgo, Alicia, et al.
Publicado: (2020)

Synthesis, characterized, QSAR studies and molecular docking of some phosphonates as COVID-19 inhibitors
por: Gholivand, Khodayar, et al.
Publicado: (2022)

QSAR study and rustic ligand-based virtual screening in a search for aminooxadiazole derivatives as PIM1 inhibitors
por: Aouidate, Adnane, et al.
Publicado: (2018)

Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
por: Tian, Yuanxin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dau7chdqhbfco9jdn7tb8pgr6n